Progenics Pharmaceuticals, Inc. (PGNX): Insiders Aren’t Crazy About It But Hedge Funds Love It

Page 1 of 2

Is Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) a good investment?

To the average investor, there are tons of indicators shareholders can use to watch publicly traded companies. Some of the most under-the-radar are hedge fund and insider trading sentiment. At Insider Monkey, our studies have shown that, historically, those who follow the best picks of the top fund managers can outpace their index-focused peers by a significant margin (see just how much).

Just as useful, positive insider trading activity is a second way to look at the investments you’re interested in. There are many motivations for a corporate insider to sell shares of his or her company, but only one, very clear reason why they would behave bullishly. Plenty of academic studies have demonstrated the useful potential of this method if piggybackers understand where to look (learn more here).

Furthermore, let’s analyze the recent info about Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX).

How have hedgies been trading Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX)?

In preparation for the third quarter, a total of 15 of the hedge funds we track were bullish in this stock, a change of 50% from the first quarter. With hedgies’ sentiment swirling, there exists a few key hedge fund managers who were boosting their holdings substantially.

Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX)Out of the hedge funds we follow, James Dondero’s Highland Capital Management had the biggest position in Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), worth close to $18.9 million, comprising 1.4% of its total 13F portfolio. Coming in second is Julian Baker and Felix Baker of Baker Bros. Advisors, with a $18.7 million position; the fund has 0.4% of its 13F portfolio invested in the stock. Other peers with similar optimism include Kevin Kotler’s Broadfin Capital, Paul Tudor Jones’s Tudor Investment Corp and Frank Brosens’s Taconic Capital.

With a general bullishness amongst the titans, specific money managers were leading the bulls’ herd. Highland Capital Management, managed by James Dondero, assembled the most valuable position in Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX). Highland Capital Management had 18.9 million invested in the company at the end of the quarter. Julian Baker and Felix Baker’s Baker Bros. Advisors also initiated a $18.7 million position during the quarter. The other funds with brand new PGNX positions are Kevin Kotler’s Broadfin Capital, Paul Tudor Jones’s Tudor Investment Corp, and Frank Brosens’s Taconic Capital.

Insider trading activity in Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX)

Insider buying made by high-level executives is best served when the company in question has seen transactions within the past six months. Over the last six-month time period, Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) has seen zero unique insiders purchasing, and zero insider sales (see the details of insider trades here).

We’ll also review the relationship between both of these indicators in other stocks similar to Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX). These stocks are XOMA Corp (NASDAQ:XOMA), Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY), Curis, Inc. (NASDAQ:CRIS), Cerus Corporation (NASDAQ:CERS), and Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS). This group of stocks are the members of the biotechnology industry and their market caps match PGNX’s market cap.

Page 1 of 2
blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

Best States To Practice Medicine

The 10 Best States to Have a Business

The 12 Most Expensive Apple (AAPL) Apps in the Market

The 10 Richest Billionaires in the World

10 Biggest Kickstarter Failures

The 10 Best Places to Work At

The Top 10 of Google Inc (GOOGL)’s Most Expensive Acquisitions

13 Best Cities to Visit in South America

10 Most Expensive Works of Art of All Time

The 10 Richest Banks in the World

The 10 Best-Paying Jobs in America (2014)

7 Most Expensive Foods in the World

The World’s Top 10 Earning Authors

Five Wicked and Very Expensive Items (and Other “Stuff”) Sold on eBay

10 Biggest Celebrity Bankruptcies

The Top 10 Highest Paid CEOs in 2014

The 10 Most Expensive Real Estate Cities in America

10 Most Expensive States To Live In America

The 10 Best Airlines in the World

The 10 Best-Selling Cars in 2014

The 10 Best Industries to Invest In

The 10 Most Expensive States to Own a Car In

Top 10 Business Schools in US: 2014 Rankings

Top 20 Female Billionaires in 2014

6 Movies That You Should Watch to Better Understand The Cold War

Top 15 Best Paying Jobs for Women in 2014

Top 6 Things Rich People Do Differently Every Day

5 Retirement Mistakes To Avoid (and Einstein’s Famous Quote)

11 Smartest People in the World

6 Films About the Financial World You Need To Watch (While “The Wolf” is Not Around)

Warren Buffett and Billionaires Are Crazy About These 7 Stocks

The Top 10 States With Fastest Internet Speeds

10 Best Places to Visit in USA in August

Top 10 Cities to Visit Before You Die

Top 10 Genetically Modified Food In the US

15 Highest Grossing Movies Opening Weekend

5 Best Poker Books For Beginners

10 Strategies Hedge Funds Use to Make Huge Returns

Top 10 Fast Food Franchises to Buy

10 Best Places to Visit in Canada

Best Summer Jobs for Teachers

10 Youngest Hedge Fund Billionaires

Top 10 One Hit Wonders of the 90s

Fastest Growing Cities In America

Top 10 U.S. Cities for Freelancers

Top 9 Most Popular Free iPhone Apps

Top 10 Least Expensive Private Business Schools in the US

Top 15 Most Expensive Countries in the World – 2014

Top 6 Tax Scams and How to Protect Yourself

Top Businesses to Invest In

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!